ERBB2 and breast cancer: Taken together, ours results suggest that BthTX-I exerts a noticeable cytotoxicitytowards luminal (MCF7), HER-2-enriched (SKBR3), and triple-negative (MDAMB231)breast-cancer-cell lines.